联盛化学1月22日获融资买入871.36万元,融资余额6808.72万元

Group 1 - The core viewpoint of the news is that Liansheng Chemical has shown significant trading activity with a notable financing balance, indicating high investor interest despite a slight decline in stock price [1] - On January 22, Liansheng Chemical's stock price fell by 1.14%, with a trading volume of 87.32 million yuan and a net financing purchase of 1.49 million yuan [1] - As of January 22, the total financing and securities lending balance for Liansheng Chemical was 68.42 million yuan, with a financing balance of 68.09 million yuan, accounting for 1.96% of the circulating market value, which is above the 90th percentile level over the past year [1] Group 2 - As of September 30, the number of shareholders for Liansheng Chemical was 7,270, a decrease of 16.41% compared to the previous period, while the average circulating shares per person increased by 19.63% to 12,895 shares [2] - For the period from January to September 2025, Liansheng Chemical achieved an operating income of 506 million yuan, representing a year-on-year growth of 18.06%, while the net profit attributable to the parent company was 12.41 million yuan, a decrease of 8.20% year-on-year [2] Group 3 - Since its A-share listing, Liansheng Chemical has distributed a total of 97.52 million yuan in dividends, with 75.38 million yuan distributed over the past three years [3]

RealsunChem-联盛化学1月22日获融资买入871.36万元,融资余额6808.72万元 - Reportify